More importantly, we show that Fringe can modulate the glioma cell fate decisions by regulating the Notch1 signaling, i.e., realizing the transition of grades III ∼ IV to grades I ∼ II, and then to normal brain tissue. This evidence concerns the gene NOTCH1 and central nervous system cancer.